Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Iqvia Holdings Inc (IQV)

168.81   -1.06 (-0.62%) 11-29 20:52
Open: 170.48 Pre. Close: 169.87
High: 170.89 Low: 168.03
Volume: 591,766 Market Cap: 32,365M
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support services; and strategic planning and design services, as well as clinical trial, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. The company has a strategic alliance with ACCORD-2 to provide single research platform to speed development of new COVID-19 treatments. IQVIA Holdings Inc. serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 171.066 - 171.999 171.999 - 172.775
Low: 165.74 - 166.917 166.917 - 167.896
Close: 167.037 - 168.833 168.833 - 170.324

Technical analysis

as of: 2020-11-29 9:23:38 AM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 211.14     One year: 246.61
Support: Support1: 162.16    Support2: 150.66
Resistance: Resistance1: 180.77    Resistance2: 211.14
Pivot: 170.42
Moving Average: MA(5): 170.20     MA(20): 168.41
MA(100): 161.21     MA(250): 148.84
MACD: MACD(12,26): 1.84     Signal(9): 2.10
Stochastic oscillator: %K(14,3): 34.52     %D(3): 45.65
RSI: RSI(14): 51.89
52-week: High: 180.77  Low: 81.79  Change(%): 17.3
Average Vol(K): 3-Month: 99163  10-Days: 69626

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
IQV has closed above bottom band by 32.5%. Bollinger Bands are 46.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to IQV's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 27 Nov 2020
Is There Now An Opportunity In IQVIA Holdings Inc. (NYSE:IQV)? - Simply Wall St

Thu, 26 Nov 2020
Equities Analysts Issue Forecasts for IQVIA Holdings Inc.'s FY2021 Earnings (NYSE:IQV) - MarketBeat

Wed, 25 Nov 2020
Insider Selling: IQVIA Holdings Inc. (NYSE:IQV) Director Sells 9,590 Shares of Stock - MarketBeat

Mon, 23 Nov 2020
Is Iqvia Holdings Inc (IQV) Stock Worth a Buy Monday? - InvestorsObserver

Thu, 19 Nov 2020
IQVIA (IQV) Down 0.1% Since Last Earnings Report: Can It Rebound? - Nasdaq

Fri, 13 Nov 2020
Nov 13, 2020 - Kdi Capital Partners Llc Buys Keysight Technologies Inc, IQVIA Holdings Inc, JPMorgan Chase, Sells Microsoft Corp, Inc, Adobe Inc -

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 192
Shares Float (M) 190
% Held by Insiders 0.76
% Held by Institutions 93.27
Shares Short (K) 1,900
Shares Short P. Month (K) 2,400

Stock Financials

EPS 0.910
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 30.500
Profit Margin 1.61
Operating Margin 6.49
Return on Assets (ttm) 1.9
Return on Equity (ttm) 3.2
Qtrly Rev. Growth 0.6
Gross Profit (p.s.) 19.767
Sales Per Share 57.164
EBITDA (p.s.) 9.232
Qtrly Earnings Growth 77.20
Operating Cash Flow (M) 1,790
Levered Free Cash Flow (M) 1,490

Stock Valuations

PE Ratio 185.51
PEG Ratio 1.22
Price to Book value 5.53
Price to Sales 2.95
Price to Cash Flow 18.08

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.